Seeking AlphaThu, 14 May 2026 20:40:55 GMTXenon Pharmaceuticals Inc. (XENE) Presents at Bank of America Global Healthcare Conference 2026 TranscriptXENE+1.17%
Zacks Investment ResearchFri, 08 May 2026 17:50:40 GMTXenon Q1 Earnings Match Estimates, Pipeline Development in FocusXENE+1.17%
Seeking AlphaFri, 08 May 2026 07:41:17 GMTXenon Pharmaceuticals Inc. (XENE) Q1 2026 Earnings Call TranscriptXENE+1.17%
Seeking AlphaWed, 22 Apr 2026 20:51:19 GMTXenon's Phase 3 Supports A 'Buy' Despite Its PremiumXENE+1.17%
The Motley FoolFri, 27 Mar 2026 23:03:01 GMTXenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should KnowXENE+1.17%
Zacks Investment ResearchThu, 19 Mar 2026 17:01:26 GMTXenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's WhyXENE+1.17%
Zacks Investment ResearchTue, 10 Mar 2026 16:30:39 GMTXENE Stock Up as Azetukalner Meets Goal in Focal Onset Seizures StudyXENE+1.17%
24/7 Wall StreetMon, 09 Mar 2026 23:00:00 GMT50% and 61% Gains in a Single Day: Why XENE and RLMD Soared TodayXENE+1.17%
BenzingaMon, 09 Mar 2026 18:50:02 GMTCrude Oil Rises Around 4%; Xenon Pharmaceuticals Shares SurgeXENE+1.17%
Seeking AlphaMon, 09 Mar 2026 18:17:59 GMTXenon Pharmaceuticals Inc. (XENE) Discusses Positive Top Line Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures TranscriptXENE+1.17%
Seeking AlphaMon, 09 Mar 2026 15:56:27 GMTXenon: Shares Soar On Seizure Data, But Valuation May Be OvercookedXENE+1.17%
BenzingaMon, 09 Mar 2026 13:26:01 GMTXenon Pharmaceuticals Rallies After Pivotal Data Shows Major Drop In Monthly SeizuresXENE+1.17%
Investors Business DailyMon, 09 Mar 2026 13:15:48 GMTThe 'Unprecedented' Results That Could Nab Xenon A GW- Or Intra-Cellular-Like DealXENE+1.17%
Zacks Investment ResearchFri, 27 Feb 2026 15:42:01 GMTXenon Q4 Loss Wider Than Expected, Pipeline Development in FocusXENE+1.17%
